Dissolution study of nanocrystal powders of a poorly soluble drug by UV imaging and channel flow methods

European Journal of Pharmaceutical Sciences

Volumn 50, Issue 3-4, 2013, Pages 511-519

  Sarnes, Annika ^a   Østergaard, Jesper ^b   Jensen, Sabrine Smedegaard ^b   Aaltonen, Jaakko ^a   Rantanen, Jukka ^b   Hirvonen, Jouni ^a   Peltonen, Leena ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Channel flow method; Dissolution rate; Nanocrystals; Poloxamer; Solubility; UV imaging

Indexed keywords

INDOMETACIN; NANOCRYSTAL; NANOMATERIAL; POLOXAMER; POLYSORBATE 80;

ARTICLE; DISSOLUTION; DRUG SOLUBILITY; FLOW MEASUREMENT; IMAGING SYSTEM; PARTICLE SIZE; POWDER; PRIORITY JOURNAL; SOLID STATE; SURFACE PROPERTY; SUSPENSION; ULTRAVIOLET RADIATION;

CHANNEL FLOW METHOD; DISSOLUTION RATE; NANOCRYSTALS; POLOXAMER; SOLUBILITY; UV IMAGING;

DRUG COMPOUNDING; DRUG STABILITY; INDOMETHACIN; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; POLOXAMER; POLYSORBATES; POWDERS; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84883720508     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.08.030     Document Type: Article

References (45)

1. J. Aaltonen, P. Heinänen, L. Peltonen, H. Kortejärvi, V.P. Tanninen, L. Christiansen, J. Hirvonen, J. Yliruusi, and J. Rantanen In situ measurement of solvent-mediated phase transformations during dissolution testing J. Pharm. Sci. 95 2006 2730 2737 (Pubitemid 46093179)
2. G.E. Amidon, and M. Hawley Oral bioperformance and 21st century dissolution Mol. Pharm. 2010
3. BASF, 2004. Pluronic® F68 ja F127, blockpolymer, surfactant. < http://worldaccount.basf.com/wa/NAFTA~en-US/Catalog/ChemicalsNAFTA/pi/BASF/ Brand/pluronic/brand-top/ >.
4. J. Boetker, M. Savolainen, V. Koradia, F. Tian, T. Rades, A. Müllertz, C. Cornett, J. Rantanen, and J. Østergaard Insights into the early dissolution events of amlo. [Mol Pharm. 2011] - PubMed - NCBI Mol. Pharm. 8 2011 1372 1380
5. S.P. Chamarthy, and R. Pinal The nature of crystal disorder in milled pharmaceutical materials Colloids Surf. Physicochem. Eng. Aspects 331 2008 68 75
6. C.A. Coutts-Lendon, N.A. Wright, E.V. Mieso, and J.L. Koenig The use of FT-IR imaging as an analytical tool for the characterization of drug delivery systems J. Control. Release 93 2003 223 248 (Pubitemid 37485946)
7. 1H NMR and NMR microimaging study J. Controlled Release 122 2007 199 205 (Pubitemid 47361408)
8. A. Dokoumetzidis, and P. Macheras A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system Int. J. Pharm. 321 2006 1 11 (Pubitemid 44247428)
9. European Pharmacopoeia, 2011. Monographs: Indomethacin, seventh ed.
10. S. Gordon, K. Naelapää, J. Rantanen, A. Selen, A. Müllertz, and J. Ostergaard Real-time dissolution behavior of furosemide in biorelevant media as determined by UV imaging 2012 Pharm. Dev. Technol.
11. K. Greco, and R. Bogner Solution-mediated phase transformation: significance during dissolution and implications for bioavailability J. Pharm. Sci. 2011 101
12. S. Hagan, A. Coombes, M. Garnett, S. Dunn, M. Davies, L. Illum, S. Davis, S. Harding, S. Purkiss, and P. Gellert Polylactide-poly(ethylene glycol) copolymers as drug delivery systems. 1. Characterization of water dispersible micelle-forming systems - Langmuir (ACS publications) Langmuir 12 1996 2153 2161 (Pubitemid 126564672)
13. J. Hecq, M. Deleers, D. Fanara, H. Vranckx, and K. Amighi Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine Int. J. Pharm. 299 2005 167 177 (Pubitemid 40962418)
14. S.G. Kazarian, and K.L.A. Chan Applications of ATR-FTIR spectroscopic imaging to biomedical samples Biochim. Biophys. Acta (BBA) - Biomembranes 1758 2006 858 867 (Pubitemid 44223427)
15. S.G. Kazarian, and J. van der Weerd Simultaneous FTIR spectroscopic imaging and visible photography to monitor tablet dissolution and drug release Pharm Res. 25 2008 853 860 (Pubitemid 351661828)
16. C.M. Keck, and R.H. Müller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16 (Pubitemid 41736019)
17. J.E. Kipp The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs Int. J. Pharm. 284 2004 109 122 (Pubitemid 39349144)
18. P. Kocbek, S. Baumgartner, and J. Kristl Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs Int J. Pharm. 312 2006 179 186
19. J. Kowalczuk, and J. Tritt-Goc A possible application of magnetic resonance imaging for pharmaceutical research Eur. J. Pharm. Sci. 42 2011 354 364
20. Lan, Y., Shaukat, A., Langley, N., 2013. Poloxamers as Solubilizing Agents in Solid Dispersions.
21. P. Liu, X. Rong, J. Laru, B. van Veen, J. Kiesvaara, J. Hirvonen, T. Laaksonen, and L. Peltonen Nanosuspensions of poorly soluble drugs: Preparation and development by wet milling Int. J. Pharm. 411 2011 215 222
22. S.A. Maskarinec, J. Hannig, R.C. Lee, and K.Y.C. Lee Direct observation of poloxamer 188 insertion into lipid monolayers Biophys. J. 82 2002 1453 1459 (Pubitemid 34204765)
23. M. McAllister Dynamic dissolution: a step closer to predictive dissolution testing? Mol. Pharm. 2010
24. E. Merisko-Liversidge, and G.G. Liversidge Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology Adv. Drug Deliv. Rev. 63 2011 427 440
25. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 2003 113 120 (Pubitemid 36184748)
26. H. Metz, and K. Mader Benchtop-NMR and MRI - a new analytical tool in drug delivery research Int. J. Pharm. 364 2008 170 175
27. R.H. Muller, and C. Jacobs Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability Int J. Pharm. 237 2002 151 161 (Pubitemid 34310488)
28. K.P. Nott Magnetic resonance imaging of tablet dissolution Eur. J. Pharm. Biopharm. 74 2010 78 83
29. J. Ostergaard, E. Meng-Lund, S.W. Larsen, C. Larsen, K. Petersson, J. Lenke, and H. Jensen Real-time UV imaging of nicotine release from transdermal patch Pharm. Res. 2010
30. J. Østergaard, F. Ye, J. Rantanen, A. Yaghmur, S.W. Larsen, C. Larsen, and H. Jensen Monitoring lidocaine single-crystal dissolution by ultraviolet imaging J. Pharm. Sci. 2011 100
31. L. Peltonen, and J. Hirvonen Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods J. Pharm. Pharmacol. 62 2010 1569 1579
32. L. Peltonen, P. Liljeroth, T. Heikkilä, K. Kontturi, and J. Hirvonen Dissolution testing of acetylsalicylic acid by a channel flow method - correlation to USP basket and intrinsic dissolution methods Eur. J. Pharm. Sci. 19 2003 395 401 (Pubitemid 36952401)
33. N.L. Prasanthi, S.S. Manikiran, S. Sowmya, B. Anusha, and N. Rama Rao Effect of poloxamer 188 on in vitro dissolution properties of solid dispersions Int. J. Pharm. Sci. Rev. Res. 2 2011 27 32
34. B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796 (Pubitemid 39242830)
35. S. Sepassi, D.J. Goodwin, A.F. Drake, S. Holland, G. Leonard, L. Martini, and M.J. Lawrence Effect of polymer molecular weight on the production of drug nanoparticles J. Pharm. Sci. 96 2007 2655 2666 (Pubitemid 47597816)
36. J. van der Weerd, and S.G. Kazarian Combined approach of FTIR imaging and conventional dissolution tests applied to drug release J. Control. Release 98 2004 295 305 (Pubitemid 38950738)
37. J. van der Weerd, K.L. Andrew Chan, and S.G. Kazarian An innovative design of compaction cell for in situ FT-IR imaging of tablet dissolution Vib. Spectrosc. 35 2004 9 13
38. J. van der Weerd, and S.G. Kazarian Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests J. Pharm. Sci. 94 2005 2096 2109 (Pubitemid 41551492)
39. B. Van Eerdenbrugh, D.E. Alonzo, and L.S. Taylor Influence of particle size on the ultraviolet spectrum of particulate-containing solutions: implications for in-situ concentration monitoring using UV/Vis fiber-optic probes Pharm. Res. 28 2011 1643 1652
40. B. Van Eerdenbrugh, L. Froyen, J. Van Humbeeck, J.A. Martens, P. Augustijns, and G. Van den Mooter Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion Eur. J. Pharm. Sci. 35 2008 127 135
41. B. Van Eerdenbrugh, G. Van den Mooter, and P. Augustijns Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products Int. J. Pharm. 364 2008 64 75
42. J. Wang, L. Urban, and D. Bojanic Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety Expert Opin Drug Metab. Toxicol. 3 2007 641 665 (Pubitemid 351320635)
43. M. Windbergs, M. Jurna, H.L. Offerhaus, J.L. Herek, P. Kleinebudde, and C.J. Strachan Chemical imaging of oral solid dosage forms and changes upon dissolution using coherent anti-stokes Raman scattering microscopy Anal. Chem. 81 2009 2085 2091
44. S.K. Yadav, S. Mishra, and B. Mishra Eudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluation AAPS PharmSciTech 2012
45. F. Ye, A. Yaghmur, H. Jensen, S.W. Larsen, C. Larsen, and J. Østergaard Real-time UV imaging of drug diffusion and release from Pluronic F127 hydrogels Eur. J. Pharm. Sci. 43 2011 236 243